ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,031Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 682

$1.57M Total Retail Price of All Prescriptions

Rank: 30 out of 682

813 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 813 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 813 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 18,768 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LEVOTHYROXINE SODIUM 1,072 801 1 3
LISINOPRIL 966 634 2 2
OMEPRAZOLE 875 616 3 5
HYDROCODONE-ACETAMINOPHEN 862 502 S3 4 1
FUROSEMIDE 765 599 5 7
SIMVASTATIN 549 406 6 4
POTASSIUM CHLORIDE 546 393 7 14
WARFARIN SODIUM 546 446 7 13
METFORMIN HCL 532 310 9 8
AMLODIPINE BESYLATE 461 342 10 6
GABAPENTIN 407 226 11 9
HYDROCHLOROTHIAZIDE 371 249 12 12
CITALOPRAM HBR 356 231 13 17
ZOLPIDEM TARTRATE 353 211 14 21
METOPROLOL TARTRATE 344 275 15 10
NEXIUM 285 176 16 19
MELOXICAM 275 189 17 27
METOPROLOL SUCCINATE 272 203 18 16
CIPROFLOXACIN HCL 263 223 19 58
METHYLPREDNISOLONE 254 169 20 127
AZITHROMYCIN 241 165 21 39
GLIMEPIRIDE 240 168 22 43
PAROXETINE HCL 235 157 23 53
PRAVASTATIN SODIUM 233 155 24 15
LOSARTAN POTASSIUM 227 169 25 20
CYMBALTA 219 153 26 51
ATORVASTATIN CALCIUM 217 176 27 11
ATENOLOL 210 143 28 18
MIRTAZAPINE 206 191 29 52
BUSPIRONE HCL 200 85 30 102
CRESTOR 199 135 31 22
AMITRIPTYLINE HCL 197 118 R 32 50
TAMSULOSIN HCL 191 164 33 33
CLOPIDOGREL 184 152 34 25
QUETIAPINE FUMARATE 173 149 35 87
DIOVAN 168 105 36 42
PANTOPRAZOLE SODIUM 167 149 37 29
CYCLOBENZAPRINE HCL 166 71 R 38 65
NAMENDA 165 158 39 41
CLONIDINE HCL 156 87 40 48
ROPINIROLE HCL 152 96 41 71
SYNTHROID 150 113 42 59
DIGOXIN 150 139 42 46
PROMETHAZINE HCL 147 70 R 44 54
PLAVIX 146 114 45 35
TRAMADOL HCL 145 120 46 26
TRIAMTERENE-HCTZ 143 115 47 57
LANTUS 136 80 48 55
RANITIDINE HCL 135 88 49 28
ISOSORBIDE MONONITRATE ER 133 96 50 31
METFORMIN HCL ER 132 92 51 68
FLUTICASONE PROPIONATE 131 105 52 36
TRAZODONE HCL 128 79 53 38
POLYETHYLENE GLYCOL 3350 127 93 54 44
FLUOXETINE HCL 122 75 55 60
DONEPEZIL HCL 121 121 56 30
FINASTERIDE 120 110 57 131
PREDNISONE 119 78 58 40
SPIRONOLACTONE 117 76 59 64
CELEBREX 116 87 60 80
ESCITALOPRAM OXALATE 114 96 61 73
LYRICA 113 48 62 78
KLOR-CON M20 112 95 63 67
PROAIR HFA 111 61 64 45
FAMOTIDINE 104 81 65 99
RAMIPRIL 102 88 66 81
SUCRALFATE 100 70 67 160
ALLOPURINOL 100 72 67 32
ESTRADIOL 100 69 R 67 152
SERTRALINE HCL 99 68 70 24
PREMARIN 98 74 R 71 132
ABILIFY 97 45 72 179
JANUVIA 97 62 72 62
LEVETIRACETAM 96 75 74 125
FENOFIBRATE 92 36 75 76
CARVEDILOL 92 82 75 23
ADVAIR DISKUS 91 63 77 47
LEVOFLOXACIN 90 76 78 70
LOVAZA 86 22 79 106
LANSOPRAZOLE 84 39 80 85
IRBESARTAN 84 82 80 234
MECLIZINE HCL 83 71 82 124
ALENDRONATE SODIUM 82 77 83 37
SINGULAIR 81 36 84 63
PROPRANOLOL HCL 81 49 84 141
FLUCONAZOLE 80 43 86 154
VENLAFAXINE HCL ER 79 46 87 119
CEFDINIR 77 60 88 157
NITROFURANTOIN MONO-MACRO 77 71 88 204
SPIRIVA 76 42 90 49
DOXYCYCLINE HYCLATE 76 48 90 137
GEMFIBROZIL 74 48 92 122
GLIPIZIDE 74 38 92 61
INSULIN SYRINGE 73 56 94 75
LISINOPRIL-HYDROCHLOROTHIAZIDE 73 29 94 34
TRICOR 73 22 94 94
NAPROXEN 72 56 97 97
ZETIA 71 37 98 69
TOPIRAMATE 69 12 99 150
TIZANIDINE HCL 68 20 100 83
ENALAPRIL MALEATE 68 59 100 91
NOVOLOG 68 58 100 129
CILOSTAZOL 67 18 103 183
NYSTATIN 66 49 104 95
WELCHOL 66 30 104 232
DIOVAN HCT 63 41 106 109
DILTIAZEM 24HR CD 63 48 106 123
LOSARTAN-HYDROCHLOROTHIAZIDE 63 52 106 56
SEROQUEL 62 56 109 193
BUMETANIDE 62 36 109 115
METHOTREXATE 60 0 111 248
DICLOFENAC SODIUM 60 39 111 107
LIPITOR 60 36 111 92
HYDROXYZINE PAMOATE 60 39 R 111 172
CARBIDOPA-LEVODOPA 59 43 115 121
PRADAXA 57 46 116 231
BUPROPION XL 57 44 116 207
ULORIC 56 38 118 272
LIDODERM 56 27 118 134
NITROFURANTOIN 55 54 120 233
BENICAR 54 53 121 202
IBUPROFEN 54 44 121 79
PEN NEEDLE 53 34 123 159
ONGLYZA 52 36 124 219
MUPIROCIN 52 32 124 166
OXYCODONE HCL-ACETAMINOPHEN 52 22 S2 124 98
LUNESTA 52 50 124 380
METOCLOPRAMIDE HCL 50 36 128 111
LOVASTATIN 50 45 128 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.